# A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension

> **NCT00046163** · PHASE4 · TERMINATED · sponsor: **Shire** · enrollment: 150 (—)

## Conditions studied

- Hypotension, Orthostatic

## Interventions

- **DRUG:** midodrine hydrochloride (ProAmatine®)

## Key facts

- **NCT ID:** NCT00046163
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09-05
- **Primary completion:** 2003-08-06
- **Final completion:** 2003-08-06
- **Target enrollment:** 150 (—)
- **Why stopped:** Study was terminated due to poor enrollment
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046163, "A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00046163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*